Clinical Trial Update: Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic

View source ↗

Summary

A University of Bonn clinical trial is currently recruiting to assess a biomarker in patients with giant cell arteritis and polymyalgia rheumatica.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis
• Polymyalgia Rheumatica

Snippet

Sponsor: University of Bonn | Conditions: Giant Cell Arteritis, Polymyalgia Rheumatica | Status: RECRUITING